Last update:
HIV & AIDS news
HIV & AIDS
Single vaccine dose shows 84% effectiveness against mpox, but insufficient for HIV patients
Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine fails to offer sufficient ...
2 hours ago
0
0
HIV & AIDS
Study shows significant progress in HIV treatment initiation in the Asia-Pacific region
In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the Asia-Pacific region. This ...
5 hours ago
0
0
Machine learning could help predict adherence to HIV treatment in adolescents
Nearly 85% of the 1.7 million adolescents with HIV live in sub-Saharan Africa, along with half of the nearly 40 million people in the world living with HIV. Although the government in Uganda provides antiretroviral treatment ...
Mar 17, 2025
0
0
HIV doctors urge US to reverse 'catastrophic' funding cuts
Hundreds of HIV doctors and researchers have called on the Trump administration to reverse its sweeping aid funding cuts, saying they are "doing catastrophic harm" to the global fight against AIDS.
Mar 15, 2025
0
2
Researchers develop method to identify dormant cells that carry HIV
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure for the infection affecting ...
Mar 13, 2025
0
15
HIV's latent reservoir: New insights into Nef protein offer potential strategy to improve treatment
A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human immunodeficiency virus (HIV) hides dormant inside of cells shrinks when treated.
Mar 13, 2025
0
7
Reformulation of HIV prevention drug lenacapavir makes it last for a year
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV prevention drug lenacapavir allows it to persist in the body for up to a year. In their paper published ...
Study highlights gaps in HPV-related cancer prevention for people living with HIV
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
Mar 12, 2025
0
0
Study examines a novel way to bring addiction care and HIV prevention to people who inject drugs
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
Mar 12, 2025
0
0
People with HIV in Malawi face greater risk for dementia
Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according to a new study by a team of US and Malawian researchers.
Mar 12, 2025
0
0
Immune response may be harnessed to control HIV, primary trial results suggest
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies.
Mar 11, 2025
0
0
Trump is cancelling a republican project to wipe out AIDS, putting millions of lives at risk
Enormous progress has been made in tackling the global HIV epidemics over the past two decades. The number of people dying from HIV-related causes has fallen by 51% since 2010; and the number of annual new infections has ...
Mar 11, 2025
0
0
Long-acting injectable HIV therapy offers hope for those unable to take pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UCSF has found.
Mar 6, 2025
0
29
Pepfar funding to fight HIV/AIDS has saved 26 million lives since 2003: how cutting it will hurt Africa
The US President's Emergency Plan for AIDS Relief has been a cornerstone of global HIV/AIDS prevention, care and treatment for over two decades. Pepfar has enjoyed broad bipartisan support in the US, but its future is now ...
Mar 4, 2025
0
0
Health risks in people with HIV still possible despite successful therapy, study shows
A new study reveals that a significant proportion of people living with HIV (PWH) on long-term antiretroviral therapy remain at risk of immune and metabolic complications despite successful viral suppression. The findings ...
Feb 28, 2025
1
37
Scientists discover the function of a mysterious HIV component
Researchers from the Max Planck Institute of Biochemistry have discovered the mechanism behind an important step in the life cycle of HIV. Working together with teams at Heidelberg and Yale Universities, they found that the ...
Feb 27, 2025
0
44
HIV stigma tied to moral judgments, complicating destigmatization efforts
Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns that have taken place in the U.S. in the four decades since its initial discovery. Scientists have ...
Feb 21, 2025
0
0
New paper-based device boosts HIV test accuracy from dried blood samples
In parts of the world where traveling to a clinic for routine blood tests is a financial and logistical challenge, HIV patients increasingly have the option to collect and ship a drop of their blood in paper-based devices ...
Feb 19, 2025
0
43
Drug therapy lenacapavir may effectively control HIV in Uganda
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Feb 19, 2025
0
0
Transforming HIV diagnosis: A low-cost, point-of-care detection solution
A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency virus (HIV) detection that combines paper-based sample preparation with real-time isothermal amplification. ...
Feb 19, 2025
1
0
Methadone treatment shown to improve HIV care for formerly incarcerated individuals
When transitioning from prison to the community, formerly incarcerated individuals face numerous challenges, including lack of employment, housing, and health care. This transition is more precarious for those with HIV or ...
Feb 19, 2025
0
0
Scientists develop new natural killer cell strategy to target HIV
Researchers at The Wistar Institute's HIV Cure and Viral Diseases Center have successfully identified a new approach using natural killer (NK) cells to target and kill the HIV-positive cells that allow the virus to persist. ...
Feb 18, 2025
0
29
HIV protein switch may help virus squeeze into host cell nucleus
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its inner core into the host cell's nuclear membrane. The findings, by a University of Pittsburgh team ...
Feb 18, 2025
0
38
Researchers look for the best ways to help people with HIV quit smoking
Human immunodeficiency virus (HIV) treatment has gotten so good that people can take a pill once a day to achieve viral suppression that lets them live much longer than anyone could have imagined just a few decades ago.
Feb 18, 2025
0
0
Q&A: Researchers discuss stigma, unequal access and aging population, all challenges to HIV care and prevention
Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and managing the virus for an aging population remain, a group of Rutgers Health experts said at a recent ...
Feb 17, 2025
0
0
